TreatSMA

Physio with Marion – This Sunday

On the 27th October at 7pm TreatSMA is hosting a live webinar alongside physio Marion Main. This will be a regular slot at the end of each month. It can be viewed on all our social media platforms live and a recording will be put up on our website afterwards.

Two topics will be covered each time relating to physio and SMA followed by a Q and A.

This month the topics are Contractures and Exercises.

If you are unable to interact with the live event and have questions please leave them in the comments or email them to lucy.frost@treatsma.uk

We are really excited to work alongside Marion and bring this to the community.

Click here to join the event

Latest Posts

  • Calling on all the community to ACT NOW to avoid losing treatments!

    Calling on all the community to ACT NOW to avoid losing treatments!

    Currently, there are two approved treatments for SMA: risdiplam and nusinersen. These treatments were initially approved temporarily under Managed Access Agreements while the NHS and NICE gathered data to assess their cost-effectiveness. Now, as these agreements come to an end, both treatments face a crucial review.

    Read more

  • NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    SMA UK are proud to join together with Treat SMA and MDUK to bring you this webinar about NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam. 2024 sees the end of the managed access agreements (MAAs) for the two treatments. An expert committee will gather to assess the new clinical and real-world evidence, along…

    Read more

  • Let the battle begin

    Let the battle begin

    This year the Managed Access Agreement for Spinraza and Risdiplam expires. The MAA was put in place five years ago so the pharmaceutical companies could gather more evidence to resubmit to NICE for approval on the NHS with Biogen extending their MAA by a year.

    Read more